Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 106

Sort by

Sort Order Select

Journal Articles

Doripenem Versus Meropenem As the First-Line Mono-Therapy in High-Risk Febrile Neutropenic Patients with Acute Leukemia: A Randomized, Controlled Trial

Tatsuo Oyake, Norifumi Sugawara, MD, PhD, Shinri Miyajima, MD, Kazuki Kiyohara, MD, Maki Nishiya, MD PhD, Tadashi Shimoyama, MD PhD, Yuka Takemasa-Fujisawa, MD PhD, Ryosei Sasaki, MD PhD, Wataru Izumita, MD, Yasuhiko Tsukushi, MD, PhD, Akihiro Otsu, MD, PhD, Takahiro Mine, MD, Takeshi Sugawara, MD, Yuzo Suzuki, MD PhD, Yoshiaki Okano, MD, PhD, Ichiro Hanamura, MD PhD, Shugo Kowata, MD, PhD, Shigeki Ito, MD, PhD

Blood (2019) 134 (Supplement_1): 4865.

https://doi.org/10.1182/blood-2019-131305

Published: 2019

Journal Articles

Ixazomib Maintenance to Prevent Alloreactivity and Provide Anti-Malignancy Effects Following Nonmyeloablative T-Replete Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide

Scott R. Solomon, MD, Melhem Solh, MD, Stacey Brown, CCRP, Katelin C Jackson, Xu Zhang, PhD, Lawrence E Morris, MD, H. Kent Holland, MD, Asad Bashey, MD PhD

Blood (2019) 134 (Supplement_1): 1998.

https://doi.org/10.1182/blood-2019-124354

Published: 2019

Journal Articles

Ibrutinib at First Relapse for Mantle Cell Lymphoma: A United Kingdom Real World Analysis of Outcomes in 169 Patients

Blood (2019) 134 (Supplement_1): 3993.

https://doi.org/10.1182/blood-2019-125947

Published: 2019

Journal Articles

Progression-Free Survival and Overall Survival Among a Patient Cohort of Relapsed/Refractory Mycosis Fungoides in France, Germany, Italy, Spain and the United Kingdom

Martine Bagot, MD PhD, Timothy Illidge, MD PhD, Nicola Pimpinelli, MD, Mehul Dalal, PhD, Athanasios Zomas, Chalid Assaf, MD, Nathalie Waser, PhD, Zhouqin He, MSc, Tina Li, MPH, Robert Sambrook, MSc, Fabrizio Trinchese, Meredith Little, Nawal Bent-Ennakhil, Pablo L. Ortiz-Romero, MD PhD

Blood (2019) 134 (Supplement_1): 5879.

https://doi.org/10.1182/blood-2019-126246

Published: 2019

Journal Articles

Single Arm, Prospective, Open-Label Phase II Trial to Evaluate the Efficacy of Isatuximab in Patients with Monoclonal Gammopathy of Renal Significance

Vikram Premkumar, MD, Suzanne Lentzsch, MD PhD, Divaya Bhutani, MD

Blood (2019) 134 (Supplement_1): 3161.

https://doi.org/10.1182/blood-2019-123496

Published: 2019

Journal Articles

Assessing Steroid Toxicity in the Elderly with Multiple Myeloma

Vidhya Nair, DO, Hadi Mohammed, MD, Sharmeen Mahmood, DO, Pushpinderdeep Singh Kahlon, MD, Philip Kuriakose, MD

Blood (2019) 134 (Supplement_1): 5557.

https://doi.org/10.1182/blood-2019-125442

Published: 2019

Journal Articles

Targeted Molecular Imaging of Translocator Protein (TSPO) Using 18F GE180-PET for the Diagnosis of Gastrointestinal Graft Versus host Disease (GI-GVHD)

Ashleigh P Scott, MBBS FRACP FRCPA, Siok-Keen Tey, MBBS PhD FRACP FRCPA, Paul Thomas, MBBS FRACP FAANMS, David Pattison, MBBS MPH FRACP FAANMS, Glen A Kennedy, MBBS FRACP FRCPA

Blood (2018) 132 (Supplement 1): 3397.

https://doi.org/10.1182/blood-2018-99-114114

Published: 2018

Journal Articles

Sequential Infusion of Tcrαβ- and CD45RA-Depleted Haploidentical Progenitor Cells Is Safe and Allows for Rapid Immune Reconstitution in Pediatric Patients with Recurrent Hematological Malignancies

Ali Y Suliman, MD MSc, Ying Li, MD PhD, David Cullins, Amanda J Sooter, Janice Riberdy, PhD, Madden Renee, MD, Ewelina Mamcarz, MD, Amr Qudeimat, MD, Akshay Sharma, MBBS, Ashok Srinivasan, MD, Aimee Talleur, MD, Anusha Sunkara, MS, Guolian Kang, PhD, Stephen Gottschalk, MD, Brandon Triplett, MD

Blood (2018) 132 (Supplement 1): 4574.

https://doi.org/10.1182/blood-2018-99-110886

Published: 2018

Journal Articles

Current Real-World Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma

Jenny Willson, Amanda Bruno, Joanna Opalinska, Jeannene Nelson, Orsolya Lunacsek, Dana Stafkey-Mailey, Joanne Willey

Blood (2018) 132 (Supplement 1): 3290.

https://doi.org/10.1182/blood-2018-99-112954

Published: 2018

Journal Articles

Development of Novel Nanobiosensor for Direct Measurement of the Oral Anticoagulant Agent: Dabigatran Etexilate

Maher M Al Johani, MBBS, Raja Chinnappana, PhD, Shimaa Eissaa, PhD, Tarek Owaidah, MDFRCPA, Dana Cialla-Mayc, PhD, Jürgen Poppc, PhD, Mohammed Zourob, PhD

Blood (2018) 132 (Supplement 1): 1247.

https://doi.org/10.1182/blood-2018-99-110689

Published: 2018

Journal Articles

Liver Complications after Allogeneic Hematopoietic Stem Cell Transplantation: Descriptive Longitudinal Study Using Liver Parameters Monitoring and Their Impact on Transplantation Outcomes Using a Prediction Score

Mauricette Michallet, MD PhD, Mohamad Sobh, Alexandre Deloire, CRA, Ali El-Kassir, PharmD, Emilie Frobert, MD, Marie-Odile Geay-Baillat, MD, Valerie Hervieu, MD, Christophe Nougier, MD, Fiorenza Barraco, MD, Helene Labussiere, MD, Christine Lombard, MD, Franck Emmanuel Nicolini, MD PhD

Blood (2017) 130 (Supplement 1): 3236.

https://doi.org/10.1182/blood.V130.Suppl_1.3236.3236

Published: 2017

Journal Articles

Randomized Study of CPX-351 for Medically Less-Fit Adults with Newly Diagnosed Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasm

Roland B. Walter, MD PhD MS, Megan Othus, PhD, Kaysey F. Orlowski, Emily N. McDaniel, Bart L. Scott, MD, Pamela S. Becker, MD PhD, Mary-Elizabeth M. Percival, MD MS, Paul C. Hendrie, MD PhD, Bruno C Medeiros, MD, Michael T. Chiarella, Arthur C. Louie, Elihu H. Estey, MD

Blood (2017) 130 (Supplement 1): 1346.

https://doi.org/10.1182/blood.V130.Suppl_1.1346.1346

Published: 2017

Journal Articles

Disease Progression on Ibrutinib Therapy Is Associated with a Poor Clinical Outcome in Chronic Lymphocytic Leukemia (CLL) Patients Managed in Standard Clinical Practice

Othman S. Akhtar, MD, Pallawi Torka, MD, Seema A. Bhat, MD, Ryan Hare, Sheila N. J. Sait, PhD, AnneMarie W. Block, PhD, Francisco J. Hernandez-Ilizaliturri, MD

Blood (2017) 130 (Supplement 1): 5350.

https://doi.org/10.1182/blood.V130.Suppl_1.5350.5350

Published: 2017

Journal Articles

Kidney Dysfunction Post-Allogeneic Transplant: High Incidence of TMA and Kidney GvHD

Hannah K. Choe, MD, Vesh Srivatana, MD, Usama Gergis, MD, Tsiporah B. Shore, MD, Sebastian A. Mayer, MD, Jingmei Hsu, MD PhD, Adrienne A. Phillips, MD MPH, Surya V. Seshan, MD, Thangamani Muthukumar, MD, Koen Van Besien, MD PhD

Blood (2017) 130 (Supplement 1): 5500.

https://doi.org/10.1182/blood.V130.Suppl_1.5500.5500

Published: 2017

Journal Articles

Multicentre Retrospective Analysis of Chronic Lymphocytic Leukaemia Patients Treated with Idelalisib, "Real World" Data from the UK and Republic of Ireland - a Cohort of 68 Patients

Blood (2017) 130 (Supplement 1): 1733.

https://doi.org/10.1182/blood.V130.Suppl_1.1733.1733

Published: 2017

Journal Articles

Treatment of Secondary Post-Transplant Engraftment Failure with Donor CD34+ Enriched, T-Cell Depleted Peripheral Blood Stem Cells Isolated By the Clinimacs® System

Paolo Caimi, MD, Jane Reese, Merle Kolk, Robert Fox, Kari Eckmeyer, RN, Erin Galloway, RN BSN, Gina Hoffman, Ehsan Malek, MD, Leland Metheny, MD, Ben K. Tomlinson, MD, Richard Creger, PhD, Brenda W. Cooper, MD, Hillard M Lazarus, MD, Marcos de Lima, MD

Blood (2017) 130 (Supplement 1): 1956.

https://doi.org/10.1182/blood.V130.Suppl_1.1956.1956

Published: 2017

Journal Articles

Clinical and Germline Risk Factors for the Occurrence of Multiple Treatment Toxicities during Childhood Acute Lymphoblastic Leukemia (ALL) Therapy

Marion K Mateos, MBBS FRACP, Toby N Trahair, MBBS FRACP PhD, Chelsea Mayoh, BSc, Pasquale M Barbaro, MBBS FRACP FRCPA, Carly George, MBBS, FRACP, Rosemary Sutton, PhD, Tamas Revesz, MDPhDD.Sc FRACP FRCPA, Draga Barbaric, MBBS FRACP, Jodie Giles, Frank Alvaro, FRACP, MBBS, Francoise Marie Mechinaud, MD FRACP, Daniel R Catchpoole, PhD BSc, Rishi Sury Kotecha, MBBChir, MRCP, FRACP, PhD, Michael CJ Quinn, BSc MSc PhD, Georgia Chenevix-Trench, BSc PhD, Stuart MacGregor, BSc MSc PhD, Luciano Dalla-Pozza, MBBS FRACP, Glenn M Marshall, MBBS, MD FRACP

Blood (2017) 130 (Supplement 1): 2102.

https://doi.org/10.1182/blood.V130.Suppl_1.2102.2102

Published: 2017

Journal Articles

Clonal Progression during First Course of Chemotherapy in Acute Myeloid Leukemia Suboptimal Responders Heralds Reinduction Failure and Early Death

Anita Tranberg Simonsen, BSc, MSc, Manja Meggendorfer, PhD, Sarah Koch, Annette Fasan, PhD, Wolfgang Kern, MD, Line Nederby, MSc, PhD, Peter Hokland, MD, Hans Beier Ommen, MD PhD

Blood (2017) 130 (Supplement 1): 1418.

https://doi.org/10.1182/blood.V130.Suppl_1.1418.1418

Published: 2017

Journal Articles

Nivolumab for Newly Diagnosed Advanced-Stage Classical Hodgkin Lymphoma (cHL): Results from the Phase 2 Checkmate 205 Study

Radhakrishnan Ramchandren, MD, Michelle A. Fanale, MD, Antonio Rueda, Philippe Armand, MD PhD, Marek Trněný, MD PhD, Tatyana A Feldman, MD, Stephen M Ansell, MD PhD, Mariano Provencio, MD, Ulrich Jaeger, MD, Jonathon B Cohen, MDMS, Kerry J Savage, BSc, MD MSc, Wolfgang Willenbacher, Mariana Sacchi, Anne Sumbul, Eva Domingo Domenech, MD

Blood (2017) 130 (Supplement 1): 651.

https://doi.org/10.1182/blood.V130.Suppl_1.651.651

Published: 2017

Journal Articles

A Multicenter Nonrandom Clinical Study of Induction Regimen of FLAG-ID and Dae in the Treatment of Childhood De Novo Acute Myeloid Leukemia in South of China:the Early Report of Efficacy and Safety

Jian Li, MD, Chunfu Li, MD, Hua Jiang, MD, Mincui Zheng, Xiangling He, Honggui Xu, Chun Chen, Hong Wen, Changgang Li, MD, Xiaoqin Feng, PhD

Blood (2017) 130 (Supplement 1): 3873.

https://doi.org/10.1182/blood.V130.Suppl_1.3873.3873

Published: 2017

NARROW

Doripenem Versus Meropenem As the First-Line Mono-Therapy in High-Risk Febrile Neutropenic Patients with Acute Leukemia: A Randomized, Controlled Trial

Ixazomib Maintenance to Prevent Alloreactivity and Provide Anti-Malignancy Effects Following Nonmyeloablative T-Replete Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide

Ibrutinib at First Relapse for Mantle Cell Lymphoma: A United Kingdom Real World Analysis of Outcomes in 169 Patients

Progression-Free Survival and Overall Survival Among a Patient Cohort of Relapsed/Refractory Mycosis Fungoides in France, Germany, Italy, Spain and the United Kingdom

Single Arm, Prospective, Open-Label Phase II Trial to Evaluate the Efficacy of Isatuximab in Patients with Monoclonal Gammopathy of Renal Significance

Assessing Steroid Toxicity in the Elderly with Multiple Myeloma

Targeted Molecular Imaging of Translocator Protein (TSPO) Using 18F GE180-PET for the Diagnosis of Gastrointestinal Graft Versus host Disease (GI-GVHD)

Sequential Infusion of Tcrαβ- and CD45RA-Depleted Haploidentical Progenitor Cells Is Safe and Allows for Rapid Immune Reconstitution in Pediatric Patients with Recurrent Hematological Malignancies

Current Real-World Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma

Development of Novel Nanobiosensor for Direct Measurement of the Oral Anticoagulant Agent: Dabigatran Etexilate

Liver Complications after Allogeneic Hematopoietic Stem Cell Transplantation: Descriptive Longitudinal Study Using Liver Parameters Monitoring and Their Impact on Transplantation Outcomes Using a Prediction Score

Randomized Study of CPX-351 for Medically Less-Fit Adults with Newly Diagnosed Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasm

Disease Progression on Ibrutinib Therapy Is Associated with a Poor Clinical Outcome in Chronic Lymphocytic Leukemia (CLL) Patients Managed in Standard Clinical Practice

Kidney Dysfunction Post-Allogeneic Transplant: High Incidence of TMA and Kidney GvHD

Multicentre Retrospective Analysis of Chronic Lymphocytic Leukaemia Patients Treated with Idelalisib, "Real World" Data from the UK and Republic of Ireland - a Cohort of 68 Patients

Treatment of Secondary Post-Transplant Engraftment Failure with Donor CD34+ Enriched, T-Cell Depleted Peripheral Blood Stem Cells Isolated By the Clinimacs® System

Clinical and Germline Risk Factors for the Occurrence of Multiple Treatment Toxicities during Childhood Acute Lymphoblastic Leukemia (ALL) Therapy

Clonal Progression during First Course of Chemotherapy in Acute Myeloid Leukemia Suboptimal Responders Heralds Reinduction Failure and Early Death

Nivolumab for Newly Diagnosed Advanced-Stage Classical Hodgkin Lymphoma (cHL): Results from the Phase 2 Checkmate 205 Study

A Multicenter Nonrandom Clinical Study of Induction Regimen of FLAG-ID and Dae in the Treatment of Childhood De Novo Acute Myeloid Leukemia in South of China:the Early Report of Efficacy and Safety

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only